These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 30315657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y, Nishie W, Izumi K, Shimizu H.
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
    Daneshpazhooh M, Ghiasi M, Lajevardi V, Nasiri N, Balighi K, Teimourpour A, Khosravi H, Saeidi V, Mahmoudi H, Chams-Davatchi C.
    Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity.
    Emtenani S, Linnemann BE, Recke A, von Georg A, Goletz S, Schmidt E, van Beek N.
    J Dermatol Sci; 2024 May; 114(2):64-70. PubMed ID: 38582700
    [Abstract] [Full Text] [Related]

  • 11. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK, Sitaru C, Recke A, Oostingh GJ, Zillikens D, Gibbs BF.
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM, Goletz S, van Beek N, Zillikens D, Benoit S, Harman K, Walton S, English J, Sticherling M, Chapman A, Levell NJ, Groves R, Williams HC, König IR, Schmidt E, members of the BLISTER Study Group.
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
    Charneux J, Lorin J, Vitry F, Antonicelli F, Reguiai Z, Barbe C, Tabary T, Grange F, Bernard P.
    Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
    [Abstract] [Full Text] [Related]

  • 19. Reactivity against the BP180 ectodomain in patients with bullous pemphigoid, mucous membrane pemphigoid, multiple sclerosis and Parkinson disease.
    Tegtmeyer J, Romagnuolo M, Hammers CM, Opelka B, Probst C, Komorowski L, Marzano AV, Schmidt E, Goletz S.
    Exp Dermatol; 2024 Jul; 33(7):e15125. PubMed ID: 38946225
    [Abstract] [Full Text] [Related]

  • 20. Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease.
    Nätynki A, Tuusa J, Hervonen K, Kaukinen K, Lindgren O, Huilaja L, Kokkonen N, Salmi T, Tasanen K.
    Front Immunol; 2020 Jul; 11():575805. PubMed ID: 33072118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.